• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DDX52 基因在 LUAD 组织中的表达表明其有作为预后生物标志物和治疗靶点的潜力。

DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target.

机构信息

Department of Thoracic Surgery, Affiliated Hospital of Nantong University, 20 Xisi Street, Nantong, 226001, China.

出版信息

Sci Rep. 2023 Oct 13;13(1):17434. doi: 10.1038/s41598-023-44347-5.

DOI:10.1038/s41598-023-44347-5
PMID:37833424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10575940/
Abstract

Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related morbidity and mortality globally. While DDX52, an ATP-dependent RNA helicase, plays a role in several biological processes, its specific involvement in LUAD is yet to be elucidated. We utilized ROC curves to determine DDX52's predictive potential for LUAD. Kaplan-Meier survival curves, along with univariate and multivariate Cox analyses, assessed the prognostic implications of DDX52 in LUAD. We constructed nomogram models to further delineate DDX52's influence on prognosis, employed GSEA for functional analysis, and used qRT-PCR to examine DDX52 expression in LUAD tissues. DDX52 expression was notably higher in LUAD tissues, suggesting its potential as a negative prognostic marker. We observed a direct relationship between DDX52 expression and advanced T and N stages, as well as higher grading and staging in LUAD patients. Cox analyses further underscored DDX52's role as an independent prognostic determinant for LUAD. GSEA insights indicated DDX52's influence on LUAD progression via multiple signaling pathways. Our nomogram, founded on DDX52 expression, effectively projected LUAD patient survival, as validated by calibration curves. Elevated DDX52 expression in LUAD tissues signals its potential as a poor prognostic marker. Our findings emphasize DDX52's role not only as an independent prognostic factor for LUAD but also as a significant influencer in its progression through diverse signaling pathways. The constructed nomogram also underscores the feasibility of predicting LUAD patient survival based on DDX52 expression.

摘要

肺腺癌 (LUAD) 仍然是全球癌症相关发病率和死亡率的主要原因。虽然 DDX52 是一种依赖 ATP 的 RNA 解旋酶,在多个生物学过程中发挥作用,但它在 LUAD 中的具体作用仍未阐明。我们利用 ROC 曲线来确定 DDX52 对 LUAD 的预测潜力。Kaplan-Meier 生存曲线以及单变量和多变量 Cox 分析评估了 DDX52 在 LUAD 中的预后意义。我们构建了列线图模型来进一步描绘 DDX52 对预后的影响,使用 GSEA 进行功能分析,并使用 qRT-PCR 检测 LUAD 组织中的 DDX52 表达。DDX52 在 LUAD 组织中的表达明显升高,表明其可能作为负预后标志物。我们观察到 DDX52 的表达与 LUAD 患者的晚期 T 和 N 分期以及更高的分级和分期之间存在直接关系。Cox 分析进一步强调了 DDX52 作为 LUAD 独立预后标志物的作用。GSEA 分析结果表明 DDX52 通过多种信号通路影响 LUAD 的进展。我们基于 DDX52 表达构建的列线图能够有效预测 LUAD 患者的生存,校准曲线验证了这一点。DDX52 在 LUAD 组织中的高表达表明其作为不良预后标志物的潜力。我们的研究结果强调了 DDX52 不仅作为 LUAD 的独立预后因素,而且作为通过多种信号通路影响其进展的重要因素的作用。构建的列线图还强调了基于 DDX52 表达预测 LUAD 患者生存的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/12ce52b22fb4/41598_2023_44347_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c54fdd0343b2/41598_2023_44347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/061efb22b107/41598_2023_44347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c50aeea36dab/41598_2023_44347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/7072d0a9b2c0/41598_2023_44347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/3f26d220b3bc/41598_2023_44347_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c32828612dd0/41598_2023_44347_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/12ce52b22fb4/41598_2023_44347_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c54fdd0343b2/41598_2023_44347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/061efb22b107/41598_2023_44347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c50aeea36dab/41598_2023_44347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/7072d0a9b2c0/41598_2023_44347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/3f26d220b3bc/41598_2023_44347_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/c32828612dd0/41598_2023_44347_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba04/10575940/12ce52b22fb4/41598_2023_44347_Fig7_HTML.jpg

相似文献

1
DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target.DDX52 基因在 LUAD 组织中的表达表明其有作为预后生物标志物和治疗靶点的潜力。
Sci Rep. 2023 Oct 13;13(1):17434. doi: 10.1038/s41598-023-44347-5.
2
Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.利用生物信息学方法鉴定 CDT1 作为人肺腺癌的预后标志物。
PeerJ. 2023 Sep 28;11:e16166. doi: 10.7717/peerj.16166. eCollection 2023.
3
The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.PTPRH 的高表达与人类肺腺癌的不良预后相关。
Comput Math Methods Med. 2021 Jul 29;2021:9932088. doi: 10.1155/2021/9932088. eCollection 2021.
4
Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches.通过生物信息学方法鉴定KRT80作为人肺腺癌的新型预后和预测生物标志物
Comb Chem High Throughput Screen. 2024 Jun 20. doi: 10.2174/0113862073294339240603103623.
5
Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.骨形成蛋白及其受体在肺腺癌中的异常表达及预后意义。
Biomed Res Int. 2021 May 7;2021:6663990. doi: 10.1155/2021/6663990. eCollection 2021.
6
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.SEC61G 在肺腺癌中的预后价值:基于生物信息学和体外验证的综合研究。
BMC Cancer. 2021 Nov 13;21(1):1216. doi: 10.1186/s12885-021-08957-4.
7
Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.基于内质网应激相关基因构建并验证肺腺癌预后模型
Sci Rep. 2022 Nov 18;12(1):19857. doi: 10.1038/s41598-022-23852-z.
8
AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.AHNAK2 与肺腺癌不良预后和细胞迁移相关。
Biomed Res Int. 2020 Aug 20;2020:8571932. doi: 10.1155/2020/8571932. eCollection 2020.
9
Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family-related genes.基于整合素 β 家族相关基因构建肺腺癌预后风险评估模型。
J Clin Lab Anal. 2022 Jun;36(6):e24419. doi: 10.1002/jcla.24419. Epub 2022 Apr 11.
10
Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.用于预测LUAD患者预后和免疫微环境的缺氧相关基因特征
Cytokine. 2022 Apr;152:155820. doi: 10.1016/j.cyto.2022.155820. Epub 2022 Feb 14.

引用本文的文献

1
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证探索ELOVLs家族在肺腺癌中的作用
BMC Cancer. 2025 Jan 10;25(1):62. doi: 10.1186/s12885-024-13415-y.

本文引用的文献

1
APE1 promotes radiation resistance against radiation-induced pyroptosis by inhibiting the STING pathway in lung adenocarcinoma.APE1通过抑制肺腺癌中的STING通路来增强对辐射诱导的细胞焦亡的抗性。
Transl Oncol. 2023 Oct;36:101749. doi: 10.1016/j.tranon.2023.101749. Epub 2023 Aug 4.
2
CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration.CHSY3 促进胃癌的增殖和迁移,并与免疫浸润有关。
J Transl Med. 2023 Jul 17;21(1):474. doi: 10.1186/s12967-023-04333-x.
3
Cancer statistics, 2023.
癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
4
The role of costimulatory molecules in glioma biology and immune microenvironment.共刺激分子在胶质瘤生物学和免疫微环境中的作用。
Front Genet. 2022 Nov 9;13:1024922. doi: 10.3389/fgene.2022.1024922. eCollection 2022.
5
DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.DEAD-box 解旋酶 56 通过 FOXO1/p21 Cip1/c-Myc 信号通路作为癌基因促进胃癌细胞增殖和侵袭。
Bioengineered. 2022 May;13(5):13970-13985. doi: 10.1080/21655979.2022.2084235.
6
High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.PI4K2A 的高表达预示着结直肠腺癌(COAD)的预后不良,并且与免疫相关。
Cancer Med. 2023 Jan;12(1):837-851. doi: 10.1002/cam4.4895. Epub 2022 May 30.
7
Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2.浆细胞瘤变异易位 1 通过稳定 EIF4A3 生成环状 RNA LMNB2 促进肺腺癌的恶性生物学行为。
Bioengineered. 2022 Apr;13(4):10123-10140. doi: 10.1080/21655979.2022.2063666.
8
DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35.DDX10通过剪接RPL35促进结肠癌细胞的增殖和转移。
Cancer Cell Int. 2022 Feb 2;22(1):58. doi: 10.1186/s12935-022-02478-1.
9
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.UBE2T 通过 p53/AMPK/mTOR 信号通路促进肺腺癌中的自噬。
J Transl Med. 2021 Aug 30;19(1):374. doi: 10.1186/s12967-021-03056-1.
10
DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.DDX56 通过 miRNA 调节转录后 Wnt 信号通路,与鳞状细胞肺癌的早期复发相关。
Mol Cancer. 2021 Aug 26;20(1):108. doi: 10.1186/s12943-021-01403-w.